{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:11:52Z","timestamp":1773407512138,"version":"3.50.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2009,10,12]],"date-time":"2009-10-12T00:00:00Z","timestamp":1255305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0007420","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T20:34:06Z","timestamp":1255120446000},"page":"e7420","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Searching for New Clues about the Molecular Cause of Endomyocardial Fibrosis by Way of In Silico Proteomics and Analytical Chemistry"],"prefix":"10.1371","volume":"4","author":[{"given":"Misaki","family":"Wayengera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2009,10,12]]},"reference":[{"key":"ref1","first-page":"383","article-title":"The natural history of endomyocardial fibrosis.","volume":"34","author":"EH Parry","year":"1965","journal-title":"Q J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0002-8703(67)90509-1","article-title":"Endomyocardial fibrosis in Uganda (Davies&apos; disease): An epidemiologic, clinical, and pathologic study.","volume":"74","author":"DH Connor","year":"1967","journal-title":"Am Heart J"},{"key":"ref3","first-page":"10","article-title":"Endomyocardial fibrosis in Uganda.","volume":"25","author":"JNP Davies","year":"1948","journal-title":"East Afr Med J"},{"key":"ref4","first-page":"9","article-title":"Restrictive cardiomyopathy in India: the story of a vanishing mystery.","volume":"95(1)","author":"S Sivasankaran","year":"2009","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pntd.0000097","article-title":"Endomyocardial Fibrosis: Still a Mystery after 60 Years.","volume":"2(2)","author":"G Bukhman","year":"2008","journal-title":"PLoS Negl Trop"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(96)90383-9","article-title":"Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema?","volume":"347","author":"J Freers","year":"1996","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0001-706X(97)00125-3","article-title":"Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria.","volume":"69","author":"JJ Andy","year":"1998","journal-title":"Acta Trop"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/ajcn\/62.4.813","article-title":"Herman award lecture, 1995: infection-induced malnutrition - from cholera to cytokines.","volume":"62","author":"WR Beisel","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(46)90123-7","article-title":"Myocardial fibrosis following arsenical therapy: report of a case.","volume":"248","author":"J Edge","year":"1946","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00428-008-0652-3","article-title":"Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium.","volume":"453(3)","author":"SD Iglezias","year":"2008","journal-title":"Virchows Arch"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa0708629","article-title":"A population study of endomycardial fibrosis in a rural area of Mozambique.","volume":"359","author":"AO Mocumbi","year":"2008","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-3156.1999.43376.x","article-title":"Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda.","volume":"4","author":"M Rutakingirwa","year":"1999","journal-title":"Trop Med Int Health"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF02072402","article-title":"Eosinophilic disorders affecting the myocardium and endocardium: a review.","author":"CJ Spry","year":"1985","journal-title":"Heart Vessels"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1586\/14779072.7.2.169","article-title":"Epidemiology of heart failure in sub-Saharan Africa.","volume":"7(2)","author":"NB Ntusi","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PAF.0b013e3181859fe3","article-title":"Sudden death due to eosinophilic endomyocardial diseases: three case reports.","volume":"29(4)","author":"AA Turan","year":"2008","journal-title":"Am J Forensic Med Pathol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1128\/IAI.68.9.5114-5119.2000","article-title":"Modulation of Cardiocyte Functional Activity by Antibodies against <italic>Trypanosoma cruzi<\/italic> Ribosomal P2 Protein C Terminus.","volume":"68(9)","author":"P Sepulveda","year":"2000","journal-title":"Infection and Immunity"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1757-5036-2-4","article-title":"Three-dimensional studies of pathogenic peptides from the c-terminal of Trypanosoma cruzi ribosomal P proteins and their interaction with a monoclonal antibody structural model.","volume":"2(1)","author":"OA Martin","year":"2009","journal-title":"PMC Biophys"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.","volume":"25","author":"SF Altschul","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1111\/j.1742-4658.2005.04945.x","article-title":"Protein database searches using compositionally adjusted substitution matrices.","volume":"272","author":"SF Altschul","year":"2005","journal-title":"FEBS J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.176.1.201","article-title":"Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas&apos; disease patients.","volume":"176","author":"YA Skeiky","year":"1992","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/nar\/20.11.2894","article-title":"Nucleotide sequence of a cDNA encoding a Trypanosoma cruzi acidic ribosomal PO protein: a novel C-terminal domain in T. cruzi ribosomal P proteins.","volume":"20","author":"AG Schijman","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-2478(92)90087-5","article-title":"Characterization of the C-terminal region of a Trypanosoma cruzi 38-kDa ribosomal P0 protein that does not react with lupus anti-P autoantibodies.","volume":"33","author":"AG Schijman","year":"1992","journal-title":"Immunol Lett"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/nar\/18.11.3399","article-title":"Nucleotide cDNA and complete deduced amino acid sequence of a Trypanosoma cruzi ribosomal P protein (P-JL5).","volume":"18","author":"AG Schijman","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.1112631","article-title":"The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease.","volume":"309","author":"NM El-Sayed","year":"2005","journal-title":"Science"},{"key":"ref25","first-page":"571","article-title":"Protein Identification and Analysis Tools on the ExPASy Server.","author":"E Gasteiger","year":"2005"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00239-008-9132-2","article-title":"Structural Relationships Among the Ribosomal Stalk Proteins from the Three Domains of Life.","volume":"67","author":"P Grela","year":"2008","journal-title":"J Mol Evol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13815","DOI":"10.1016\/S0021-9258(18)92774-2","article-title":"Ribosomal proteins P0, P1, and P2 are phosphorylated by casein kinase II at their conserved carboxyl termini.","volume":"266","author":"P Hasler","year":"1991","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/nar\/28.3.736","article-title":"The ribosomal P-proteins of the medfly <italic>Ceratitis capitata<\/italic> form a heterogeneous stalk structure interacting with the endogenous P-proteins, in conditional P0-null strains of the yeast <italic>Saccharomyces cerevisiae<\/italic>.","volume":"28(3)","author":"ME Gagou","year":"2000","journal-title":"Nucl Acids Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3181\/00379727-99-24406","article-title":"Timed excretion of 5-hydroxy indoleacetic acid after oral administration of bananas and 5-hydroxytryptamine.","volume":"99(2)","author":"CE Lewis","year":"1958","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0140-6736(62)91303-X","article-title":"Excretion of 5-hydroxyindolylacetic acid in East Africans.","volume":"1(7225)","author":"MA Crawford","year":"1962","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/hrt.32.5.671","article-title":"The pathogenesis of endomyocardial fibrosis: the question of 5-hydroxytryptamine.","volume":"32","author":"GO Ojo","year":"1970","journal-title":"Br Heart J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-4682-6-14","article-title":"<italic>In Silico<\/italic> evidence for the species-specific conservation of mosquito retroposons: implications as a molecular biomarker.","volume":"6","author":"W Byarugaba","year":"2009","journal-title":"Theor Biol Med Model"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1073\/pnas.94.24.13028","article-title":"Determining divergence times with a protein clock: Update and reevaluation.","volume":"94","author":"DF Feng","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng0497-339","article-title":"Genome cross-referencing and XREFdb: Implications for the identification and analysis of genes mutated in human disease.","volume":"15","author":"DE Bassett","year":"1997","journal-title":"Nature Genet"},{"key":"ref35","first-page":"2630","article-title":"A space-efficient and accurate method for mapping and aligning cDNA sequences onto genomic sequence.","volume":"36(8)","author":"G Osamu","year":"2008","journal-title":"Nucl Acids Res"},{"key":"ref36","first-page":"125","article-title":"Emphasizing the vitality of genomics related research in the area of Infectious diseases.","volume":"3(4)","author":"M Wayengera","year":"2008","journal-title":"Sci Res Essay"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.","volume":"348","author":"J Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.4049\/jimmunol.173.6.3599","article-title":"Cutting edge: serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin.","volume":"173","author":"SA Boehme","year":"2004","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson&apos;s disease.","volume":"356","author":"R Zanettini","year":"2007","journal-title":"N Engl J Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0007420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T02:49:57Z","timestamp":1634006997000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0007420"}},"subtitle":[],"editor":[{"given":"Darren P.","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,12]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0007420","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,12]]}}}